Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents

被引:14
|
作者
Oliveira, M. C. [1 ]
Neto, C. [1 ]
Ribeiro Morais, G. [1 ]
Thiemann, T. [2 ]
机构
[1] Univ Tecn Lisboa, Inst Super Tecn, IST ITN, Unidade Ciencias Quim & Radiofarmaceut, P-2686953 Sacavem, Portugal
[2] United Arab Emirates Univ, Fac Sci, Al Ain, U Arab Emirates
关键词
Breast cancer; estradiol; estrogen receptor; progesterone; progesterone receptor; PET imaging; tumour targeting; POSITRON-EMISSION-TOMOGRAPHY; HUMAN ESTROGEN-RECEPTOR; 11-BETA-SUBSTITUTED ESTRADIOL DERIVATIVES; TISSUE UPTAKE SELECTIVITY; SMALL ANIMAL PET; PROGESTERONE-RECEPTOR; IN-VIVO; HIGH-AFFINITY; BINDING-AFFINITY; RAT UTERUS;
D O I
10.2174/092986713804806658
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The design and development of radiolabelled steroid derivatives has been an important area of research due to their well-known value in breast cancer targeting. The estrogen receptor (ER) and progesterone receptor (PR) are important biomarkers in the diagnosis, prognosis and follow-up of the therapeutic response of breast tumours. Thus, several radioligands based on estrogens and progestins have been proposed for targeted functional ER imaging. The aim of this review is to survey and analyze the developments in this field, which have led to the design of a number of PET steroid-based imaging agents, a few of which seem to be promising as radiopharmaceuticals for detection of ER-positive breast tumours.
引用
收藏
页码:222 / 245
页数:24
相关论文
共 50 条
  • [31] Breast Cancer and PET Imaging
    Sarikaya, Ismet
    NUCLEAR MEDICINE REVIEW, 2021, 24 (01) : 16 - 26
  • [32] HISTAMINE RECEPTOR LIGANDS AS POTENTIAL RADIOSENSITIZERS OF HUMAN BREAST CANCER CELLS
    Lamas, D. J. Martinel
    Brenzoni, P. G.
    Nunez, M. A.
    Massari, N.
    Rivera, E. S.
    Medina, V. A.
    INFLAMMATION RESEARCH, 2011, 60 : S361 - S362
  • [33] Advancing Breast Cancer Therapeutics: Targeted Gene Delivery Systems Unveiling the Potential of Estrogen Receptor-Targeting Ligands
    Lee, Jung Ro
    Kim, Young-Min
    Kim, Eun-Ji
    Jang, Mi-Kyeong
    Park, Seong-Cheol
    BIOMATERIALS RESEARCH, 2024, 28
  • [34] A potential role of FDG PET/CT as an imaging biomarker in clinically low-risk breast cancer
    Kim, Hyun Joo
    Oh, So Won
    Kim, Yu Kyeong
    Hwang, Ki-Tae
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [35] PET imaging agents targeting macrophage surface receptors
    Fu, Zhequan
    Shi, Hongcheng
    Cheng, Dengfeng
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (20): : 2104 - +
  • [36] Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-D-aspartate Receptor as Potential Imaging Agents for Brain
    Tamborini, Lucia
    Chen, Ying
    Foss, Catherine A.
    Pinto, Andrea
    Horti, Andrew G.
    Traynelis, Stephen F.
    De Micheli, Carlo
    Mease, Ronnie C.
    Hansen, Kasper B.
    Conti, Paola
    Pomper, Martin G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 11110 - 11119
  • [37] The potential role of estrogen receptor β2 in breast cancer
    Baek, Jong-Min
    Chae, Byung-Joo
    Song, Byung-Joo
    Jung, Sang-Seol
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 14 : 17 - 22
  • [38] QSAR modeling of PET imaging agents for the diagnosis of Parkinson's disease targeting dopamine receptor
    De, Priyanka
    Roy, Kunal
    THEORETICAL CHEMISTRY ACCOUNTS, 2020, 139 (12)
  • [39] New imaging agents targeting chemokine receptor CXCR4 for PET/SPECT and MRI
    Sophie Poty
    Pauline Désogère
    Kati Nicholson
    Shubhanchi Nigam
    Christine Goze
    Frédéric Boschetti
    Steve Archibald
    Helmut Maëcke
    Franck Denat
    EJNMMI Physics, 1 (Suppl 1)
  • [40] QSAR modeling of PET imaging agents for the diagnosis of Parkinson’s disease targeting dopamine receptor
    Priyanka De
    Kunal Roy
    Theoretical Chemistry Accounts, 2020, 139